Stay updated on Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThis page update includes a new revision tag (v3.4.2) and removal of older revision notices (v3.4.1) and a government-funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedA government funding notice was added stating NIH Clinical Center is open and updates can be found at opm.gov, and the page version was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check50 days agoChange DetectedThe page now includes a glossary toggle and updates several page-labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and the revision tag to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedThe changes consist of revision metadata (Revision: v3.3.4 and the previous v3.3.3) and do not modify any study content, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and RT in Localized Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and RT in Localized Bladder Cancer Clinical Trial page.